N-methyl-D-aspartate receptors (NMDAR) are heterotetrameric, ionotropic glutamate receptors, typically consisting of two GluN1 and two GluN2 subunits and play a crucial role in neuroplasticity, memory and learning. Seven different subunits lead to a variety of possible subunit combinations in NMDARs. Thus, subunit selective modulation is required for the characterization of properties and (patho)physiological relevance of NMDARs containing different subunits. TCN-201 was the first reported negative allosteric modulator with pronounced selectivity towards GluN2A containing NMDARs. The compound binds at the level of the ligand binding domains (LBD) of the receptor, more precisely at the interface of a local heterodimer of GluN1 and GluN2A LBDs. Three fluorescently labeled ligands based on the scaffold of TCN-201 were developed and autodisplay used as a tool to display the GluN1 and GluN2A LBDs on the surface of E. coli. Surface display was confirmed by proteinase K accessibility assay for GluN1 and GluN2A LBDs individually. Additionally, co-display of both LBDs within one cell sample was established. Ligand binding to surface displayed LBDs was investigated by flow cytometry. Fluorescently labeled ligands were shown to bind to LBD co-displaying cells in a concentration dependant manner. Comparing detection efficiencies suggested that fluorescein-labeled compound 3 was the most suitable tracer molecule. For compound 3 it was additionally shown that practically no off-target binding was detected for non-displaying cells and cells displaying an unrelated dimeric protein. This approach paves the road for developing a competitive binding assay with non-fluorescent ligands to identify novel GluN2A selective high-affinity binders.
Previous Article in event
Toxicity evaluation of single and combined exposures to polyhydroxybutyrate nanoparticles and caffeine using Xenopus laevis in vivo and in vitro modelsPrevious Article in session
Next Article in event Next Article in session
Autodisplay of the NMDA receptor GluN1 and GluN2A ligand binding domains as a platform for binding assays
Published: 01 November 2022 by MDPI in 8th International Electronic Conference on Medicinal Chemistry session Emerging technologies in drug discovery
https://doi.org/10.3390/ECMC2022-13462 (registering DOI)
Keywords: autodisplay; bacteria; flow cytometry; fluorescent ligand; allosteric modulator; NMDA receptor